NCT01696448View on ClinicalTrials.gov

The BANGALORE Study; Combination of Berberine, Lipoic Acid, and Picrorhiza

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

CAR-191

Patients will be randomized to the CAR-191 intervention group in a 3:1, CAR0-191:placebo ratio. There will be 30 patients in the CAR-191 treatment group.

OTHER

Placebo

Patients will be randomised in a 3:1 ratio. There will be 10 patients in the placebo group.

Trial Locations (1)

30342

Atlanta Vascular Research Foundation, Atlanta

Sponsors

Lead Sponsor

Carmel Biosciences
All Listed Sponsors
collaborator

Atlanta Vascular Research Foundation

OTHER

lead

Carmel Biosciences

INDUSTRY